A quality-by-design approach that defines potential viral contaminants of source materials can be used to achieve viral clearance.
Kathryn Martin Remington
Advertisement
Kathryn Martin Remington, PhD, is a principal scientist, development services with BioReliance by SAFC, Rockville, MD.
Articles by Kathryn Martin Remington
Advertisement
Latest Updated Articles
Application of Quality by Design to Viral SafetyPublished: October 1st 2014 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
3
Biopharma’s Digital Hopes Versus Actual Implementation
4
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
5
